Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.71 |
| ▸ | MAOB | P27338 | 5/20 | 0.65 |
| ▸ | IDO1 | P14902 | 2/20 | 0.63 |
| ▸ | HTR2A | P28223 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | HTR2B | P41595 | 1/20 | 0.61 |
| ▸ | ACP3 | P15309 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | MIF | P14174 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39655 | 1.00 | TAAR1 (0.71) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Bromide SCHEMBL11233006 | 0.98 | TAAR1 (0.69) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL11220775 | 0.98 | TAAR1 (0.69) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Iodide SCHEMBL11221836 | 0.98 | TAAR1 (0.69) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL26616857 | 0.98 | TAAR1 (0.69) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Bromide SCHEMBL31513704 | 0.98 | TAAR1 (0.69) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Ethylamine SCHEMBL4238530 | 0.94 | TAAR1 (0.65) | TAAR1MAOBIDO1HTR2AHTR2C | |
| SCHEMBL8107790 | 0.89 | TAAR1 (0.59) | TAAR1MAOBIDO1HTR2AHTR2C | |
| SCHEMBL3727416 | 0.88 | MAOB (0.61) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Acetic Acid SCHEMBL29007023 | 0.88 | TAAR1 (0.57) | TAAR1MAOBIDO1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977906-A | A-site cation-regulated halide perovskite, and preparation method and application thereof | 西北大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119899184-A | Beta-carboline compound, preparation method thereof and application thereof in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2025-04-29 | — | — | CN | claimed |
| CN-119403792-A | NO-releasing coating | W.L.戈尔及同仁股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-118440274-A | Preparation of stable porous organic polymer-based metal catalyst and application of catalyst in benzylamine dehydrogenation | 中原工学院 | 2024-08-06 | — | — | CN | claimed |
| CN-111704575-B | Synthesis method of quinoline-2-thiocarboxamide compound under conditions of no catalyst and no additive | 衡阳师范学院 | 2023-06-09 | — | — | CN | claimed |
| EP-3122743-B1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | AZEVAN PHARMACEUTICALS INC (US) | 2022-11-09 | — | — | EP | claimed |
| EP-4735422-A1 | SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF TREATING PHENYLKETONURIA AND OTHER AMINO ACIDURIAS | Sanofi (FR) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025213277-A1 | N1-(3,4-DICHLOROPHENYL)MALEAMIDE DERIVATIVES AND THE USE THEREOF IN THE TREATMENT OF INFLAMMATORY DISORDERS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025137551-A1 | AMINE PURIFICATION IN A CARBON CAPTURE METHOD USING MOF BODIES | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-120136863-A | Adrenergic receptor ADRAC2 antagonists | 拜耳公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120025328-A | Adrenergic receptor ADRAC2 antagonists | 拜耳公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-120025327-A | Adrenergic receptor ADRAC2 antagonists | 拜耳公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-120000651-A | Application of beta-carboline compounds in preparation of medicines for preventing and/or treating acute lung injury | 中国人民解放军北部战区总医院 | 2025-05-16 | — | — | CN | disclosed |
| CN-114790176-A | Imidazole compound and preparation method and application thereof | 武汉人福创新药物研发中心有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-111065635-B | Novel pyrimidine derivatives as MTH1 inhibitors | 无锡安万生物科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-4021905-A1 | INHIBITORS OF ADRENORECEPTOR ADRAC2 | Bayer Aktiengesellschaft (DE) | 2022-07-06 | — | — | EP | disclosed |
| CN-114450277-A | Substituted pyrimidines for the treatment and prevention of hepatitis B virus infection | 豪夫迈·罗氏有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-112313234-B | Pyrazolo-triazolopyrimidine derivatives as A2A receptor antagonists | 百济神州有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-114302874-A | Indole carboxamide derivatives and pharmaceutical compositions comprising same | 国际药品株式会社 | 2022-04-08 | — | — | CN | disclosed |
| CN-114286711-A | Bicyclic heterocyclic compounds as inhibitors of BCDIN3D activity | 风暴治疗有限公司 | 2022-04-05 | — | — | CN | disclosed |